Ajanta Pharma Ltd share price logo

Ajanta Pharma Ltd Share Price

(AJANTPHARM)

Mid Cap

Healthcare Sector

Check the latest share price of Ajanta Pharma Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹2585.2▲4.47%

as on 04:01PM, 02 May 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Ajanta Pharma Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹2,555.8
    Day's Price Range
    ₹2,696.5

  • 52 Week's Low

    52 Week's High

    ₹2,111.05
    52-Week Price Range
    ₹3,485
1 Month Return-1.37 %
3 Month Return-13.33 %
1 Year Return+ 8.45 %
Previous Close₹2,706.10
Open₹2,686.10
Volume1.65L
Upper Circuit₹3,247.30
Lower Circuit₹2,164.90
Market Cap₹32,292.28Cr

Ajanta Pharma Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹32,292.28 Cr

Return on Equity (ROE)

24.24

PE Ratio (TTM)

35.22

Return on capital employed (ROCE)

32.49

Beta (LTM)

0.65

P/B Ratio

8.28

Dividend Yield

2.29

PEG Ratio

4.1

EPS (TTM)

64.6

Sector

Pharmaceuticals

Technical Analysis

Bearish

View Technical Analysis

How to invest in Ajanta Pharma Ltd

Investing in Ajanta Pharma Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Ajanta Pharma Ltd or AJANTPHARM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Ajanta Pharma Ltd or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Ajanta Pharma Ltd with just a few clicks!

Ajanta Pharma Ltd Valuation

Track how the P/E of Ajanta Pharma Ltd has moved over time to understand valuation trends.

Ajanta Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (17.12x)

June 6, 2018

Today (35.22x)

May 2, 2025

Industry (54.34x)

May 2, 2025

Highest (50.52x)

September 10, 2024

LowHigh

Today’s Price to Earnings Ratio: 35.22x

Analysts Recommendation on Ajanta Pharma Ltd

Get updated buy, sell, and hold recommendations by analysts on Ajanta Pharma Ltd.

based on 12 analysts

BUY

66.67%

Buy

8.33%

Hold

25.00%

Sell

66.67% of analysts recommend a 'BUY' rating for Ajanta Pharma Ltd. Average target price of ₹3085

Source: S&P Global Market Intelligence

Analysts Forecast on Ajanta Pharma Ltd

Get share price movements and forecasts by analysts on Ajanta Pharma Ltd.

Ajanta Pharma Ltd price forecast by 12 analysts

Upside of19.33%

High

₹3667

Target

₹3085.00

Low

₹2288

Ajanta Pharma Ltd target price ₹3085, a slight upside of 19.33% compared to current price of ₹2585.2. According to 12 analysts rating.

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd Financials

Get the annual and quarterly financial summary of Ajanta Pharma Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'1 24Q'2 24Q'3 24Q'4 24Q'1 25
Revenue₹1,054.08Cr (-)₹1,144.92Cr (↑8.62%)₹1,186.64Cr (↑3.64%)₹1,146.13Cr (↓3.41%)₹1,170.41Cr (↑2.12%)
Net Income₹202.72Cr (-)₹245.77Cr (↑21.24%)₹216.48Cr (↓11.92%)₹232.88Cr (↑7.58%)₹225.26Cr (↓3.27%)
Net Profit Margin19.23% (-)21.47% (↑11.65%)18.24% (↓15.04%)20.32% (↑11.40%)19.25% (↓5.27%)
Value in ₹ crore
Details2021202220232024
Total Assets₹3,532.06Cr (-)₹3,808.64Cr (↑7.83%)₹4,339.09Cr (↑13.93%)₹4,252.44Cr (↓2.00%)
Total Liabilities₹647.08Cr (-)₹639.46Cr (↓1.18%)₹1,092.64Cr (↑70.87%)₹838.87Cr (↓23.23%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹300.88Cr (-)₹466.99Cr (↑55.21%)₹542.34Cr (↑16.14%)₹736.29Cr (↑35.76%)₹735.35Cr (↓0.13%)

Ajanta Pharma Ltd Index Inclusions

BSE Healthcare

₹41,995.12

-0.51 (▲-216.2%)

NIFTY PHARMA

₹21,627.45

-0.67 (▲-145%)

BSE 500

₹34,623.50

-0.05 (▲-16.85%)

Nifty MidSmallcap 400

₹18,151.50

-0.46 (▲-83.1%)

S&P BSE 400 MidSmallCap

₹11,047.95

-0.35 (▲-39.29%)

Nifty LargeMidcap 250

₹15,304.40

-0.33 (▲-50.75%)

BSE Mid-Cap

₹42,707.87

-0.41 (▲-175.85%)

Nifty Midcap 150

₹19,738.10

-0.68 (▲-135.05%)

S&P BSE 150 MidCap

₹14,833.59

-0.49 (▲-72.61%)

S&P BSE 250 LargeMidCap

₹10,353.59

-0.04 (▲-4.52%)

Nifty 500

₹22,006.00

-0.11 (▲-24.05%)

Ajanta Pharma Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Ajanta Pharma Ltd.

  • Ajanta Pharma Ltd Earnings Results

    Ajanta Pharma Ltd’s net profit jumped 11.12% since last year same period to ₹225.26Cr in the Q4 2024-2025. On a quarterly growth basis, Ajanta Pharma Ltd has generated -3.27% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Ajanta Pharma Ltd Dividends October,2024

    In the quarter ending September 2024, Ajanta Pharma Ltd has declared dividend of ₹28 - translating a dividend yield of 2.09%.

    Read More about Dividends

Ajanta Pharma Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Ajanta Pharma Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
66.26%
0.00
Foreign Institutions
8.86%
0.00
Mutual Funds
15.13%
0.00
Retail Investors
7.39%
0.00
Others
2.36%
0.00

Ajanta Pharma Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Ajanta Pharma Ltd with its industry peers.

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Ajanta Pharma Ltd
Ajanta Pharma Ltd
BUY₹32,292.28 Cr32.78%0.51₹816 Cr₹4,208 Cr
Sanofi India Ltd
Sanofi India Ltd
BUY₹13,704.00 Cr-5.22%0.52₹413 Cr₹2,013 Cr
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd
BUY₹71,009.90 Cr17.1%0.56₹3,168 Cr₹29,001 Cr
Zydus Lifesciences Ltd
Zydus Lifesciences Ltd
HOLD₹89,112.08 Cr33.64%0.64₹3,854 Cr₹19,547 Cr
Abbott India Ltd
Abbott India Ltd
BUY₹65,290.63 Cr13.77%0.53NANA
See all

Ajanta Pharma Ltd News & Key Events

Latest news and events at one place to help you take investing decisions in Ajanta Pharma Ltd.

  • Ajanta Pharma Reports Growth and Target Price Revision - 02 May, 2025

    Ajanta Pharma's March 2025 net sales rose 11.04% YoY. Choice Equity maintains a BUY rating, revising the target price to Rs 3,180. The stock shows a favorable bias above ₹ 2,510 support.

  • Motilal Oswal Sets Target for Ajanta Pharma - 01 May, 2025

    Motilal Oswal recommends buying Ajanta Pharma with a target price of Rs 3,260, citing strong domestic and US performance despite challenges in the anti-malaria segment.

  • Ajanta Pharma Q4 Results Show Mixed Performance - 30 Apr, 2025

    Ajanta Pharma's Q4 results revealed an 11% increase in profit and revenue, but the stock fell 2.74% on the announcement, reflecting market concerns.

  • Ajanta Pharma to Release Q4 FY 2025 Results - 22 Apr, 2025

    Ajanta Pharma Limited will announce its audited financial results for Q4 FY 2025 on April 30, 2025, followed by an earnings conference call for stakeholders.

  • Jefferies Initiates Buy on Ajanta Pharma Stock - 15 Apr, 2025

    Jefferies has initiated coverage on Ajanta Pharma with a Buy rating and a target price of ₹2,850, citing strong growth potential in branded generics markets. The firm forecasts a 19% PAT CAGR from FY25 to FY27, highlighting Ajanta's competitive advantages and consistent revenue growth.

Insights on Ajanta Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.17K Cr → 1.18K Cr (in ₹), with an average increase of 1.0% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 14.89% to 15.13% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 54.5% return, outperforming this stock by 46.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.26% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 141.8% return, outperforming this stock by 21.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 232.88 Cr → 225.26 Cr (in ₹), with an average decrease of 3.3% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AJANTPHARM stock has moved down by -6.9%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 9.26% to 8.86% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.45% to 7.39% in Mar 2025 quarter

About Ajanta Pharma Ltd

Ajanta Pharma is a specialty pharmaceutical company with a wide range of products spanning across 30 countries. It works across therapeutic segments including AntiBiotic AntiMalarial AntiDiabetic Cardiology Gynecology Orthopedics Pediatric Respiratory and General Health products. Founded in 1973, it is headquartered in Mumbai India and has a mission of Serving Global Health Care Needs Worldwide. In their 47 years of operations, they have grown their operations by adding 7 state-of-the-art manufacturing facilities, 2 in India approved by the United States Food and Drug Administration (USFDA). Their Research & Development Centre in Mumbai has a team of over 750 scientists working on innovative products that are supplied to various government bodies in India, the US market and WHO approved programmes in Africa. The company also has 6 subsidiaries and 1 step-down subsidiary worldwide with investments in capex growing from Rs 997 crore to Rs 1225 crore. In addition, the company also has undertaken buybacks of 769230 equity shares in March 2019 and 735000 equity shares in November 2020. 16 new products were launched in FY2022, including 4 1st to market products in the country, 3 new products were launched with 8 ANDAs being filed and receiving 2 final and 1 tentative approval with 20 more pending approval from the USFDA.

Revenue: ₹1,170.41Cr as on March 2025 (Q1 25)
Net Profit: ₹225.26Cr as on March 2025 (Q1 25)
Listing date: 29 May, 2000
Chairperson Name: Mannalal B Agrawal
OrganisationAjanta Pharma Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Indian Mutual Funds that own Ajanta Pharma Ltd

Check out the Mutual Funds with significant holdings in Ajanta Pharma Ltd.

FAQs

What is Ajanta Pharma Ltd price today?

Ajanta Pharma Ltd share price today stands at ₹2585.2, Open: ₹2686.1, Previous Close: ₹2706.1, High: ₹2696.5, Low: ₹2555.8, 52 Week High: ₹3485, 52 Week Low: ₹2111.05.

How to Buy Ajanta Pharma Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Ajanta Pharma Ltd shares

What are today's traded volumes of Ajanta Pharma Ltd?

Today's traded volume of Ajanta Pharma Ltd(AJANTPHARM) is 1.65L.

What is today's market capitalisation of Ajanta Pharma Ltd?

Today's market capitalisation of Ajanta Pharma Ltd(AJANTPHARM) is ₹32,292.28 Cr.

What is the 52 Week High and Low Range of Ajanta Pharma Ltd?

Ajanta Pharma Ltd (AJANTPHARM)
Price
52 Week High
₹3485
52 Week Low
₹2111.05

How much percentage Ajanta Pharma Ltd is down from its 52 Week High?

Ajanta Pharma Ltd (AJANTPHARM) share price is ₹2585.2. It is down -25.82% from its 52 Week High price of ₹3485

How much percentage Ajanta Pharma Ltd is up from its 52 Week low?

Ajanta Pharma Ltd (AJANTPHARM) share price is ₹2585.2. It is up 22.46% from its 52 Week Low price of ₹2111.05